Recommendations for global hypertension monitoring and prevention

Current Hypertension Reports

Volumn 11, Issue 6, 2009, Pages 444-449

  Lee, Drew E ^a   Cooper, Richard S ^b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; ETHNIC DIFFERENCE; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MORBIDITY; MORTALITY; PREVALENCE; QUALITY OF LIFE; RACE DIFFERENCE; REVIEW; RISK FACTOR; RISK REDUCTION; SPHYGMOMANOMETER; STANDARDIZATION; STROKE; SYSTOLIC BLOOD PRESSURE;

CARDIOVASCULAR DISEASES; COST OF ILLNESS; HUMANS; HYPERTENSION; WORLD HEALTH;

EID: 72549116570     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-009-0075-9     Document Type: Review

References (59)

1. World Health Organization: Country projects. Accessed June 2009http://www.who.int/cardiovascular-diseases/priorities/secondary-prevention/ country/en/. Accessed June 2009.
2. World Health Organization: Cardiovascular Diseases (CVDs). Fact Sheet No. 317. Geneva, Switzerland: World Health Organization; 2009. Available at http://www.who.int/mediacentre/factsheets/fs317/en/. Accessed June 2009.
3. World Health Organization 2009 Cardiovascular Diseases (CVDs). Fact Sheet No. 317 World Health Organization Geneva, Switzerland World Health Organization: Cardiovascular Diseases (CVDs). Fact Sheet No. 317. Geneva, Switzerland: World Health Organization; 2009. Available at http://www.who.int/ mediacentre/factsheets/fs317/en/. Accessed June 2009.
4. World Health Organization: The World Health Report 2002-Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: World Health Organization; 2002. Available at http://www.who.int/whr/2002/en/whr02-en.pdf. Accessed June 2009.
5. World Health Organization 2002 The World Health Report 2002-Reducing Risks, Promoting Healthy Life World Health Organization Geneva, Switzerland World Health Organization: The World Health Report 2002-Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: World Health Organization; 2002. Available at http://www.who.int/whr/2002/en/whr02-en.pdf. Accessed June 2009.
6. Murray CJL, Lopez AD (eds): The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard University Press; 1996.
7. P.M. Kearney M. Whelton K. Reynolds, et al. 2005 Global burden of hypertension: analysis of worldwide data Lancet 365 217 223 15652604
8. R.S. Cooper K. Wolf-Maier A. Luke, et al. 2005 An international comparative study of blood pressure in populations of European vs. African descent BMC Med 3 2 10.1186/1741-7015-3-2 15629061 (Pubitemid 40251708)
9. K. Wolf-Maier R.S. Cooper J.R. Banegas, et al. 2003 Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States JAMA 289 2363 2369 10.1001/jama.289.18.2363 12746359 (Pubitemid 37430168)
10. World Health Organization: The Global Burden of Disease: 2004 Update. Geneva, Switzerland: World Health Organization; 2008. Available at http://www.who.int/healthinfo/global-burden-disease/GBD-report-2004update-full. pdf. Accessed June 2009.
11. World Health Organization 2008 The Global Burden of Disease: 2004 Update World Health Organization Geneva, Switzerland World Health Organization: The Global Burden of Disease: 2004 Update. Geneva, Switzerland: World Health Organization; 2008. Available at http://www.who.int/healthinfo/global-burden- disease/GBD-report-2004update-full.pdf. Accessed June 2009.
12. S. Sheridan M. Pignone K. Donahue 2003 Screening for high blood pressure: a review of the evidence for the U.S. Preventive Services Task Force Am J Prev Med 25 151 158 10.1016/S0749-3797(03)00121-1 12880884 (Pubitemid 36918355)
13. Chobanian AV, Bakris GL, Black HR, et al.: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: JNC 7 Express. Bethesda, MD: National Heart, Lung, and Blood Institute; 2003. Available at http://www.nhlbi.nih.gov/guidelines/ hypertension/express.pdf. Accessed June 2009.
14. A.V. Chobanian G.L. Bakris H.R. Black, et al. 2003 The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: JNC 7 Express National Heart, Lung, and Blood Institute Bethesda, MD Chobanian AV, Bakris GL, Black HR, et al.: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: JNC 7 Express. Bethesda, MD: National Heart, Lung, and Blood Institute; 2003. Available at http://www.nhlbi.nih.gov/guidelines/ hypertension/express.pdf. Accessed June 2009.
15. Ostchega Y, Yoon SS, Hughes J, Louis T: Hypertension Awareness, Treatment, and Control-Continued Disparities in Adults: United States, 2005-2006. NCHS Data Brief No 3. Hyattsville, MD: National Center for Health Statistics; 2008. Available at http://www.cdc.gov/nchs/data/databriefs/db03.pdf. Accessed June 2009.
16. Y. Ostchega S.S. Yoon J. Hughes T. Louis 2008 Hypertension Awareness, Treatment, and Control-Continued Disparities in Adults: United States, 2005-2006. NCHS Data Brief No 3 National Center for Health Statistics Hyattsville, MD Ostchega Y, Yoon SS, Hughes J, Louis T: Hypertension Awareness, Treatment, and Control-Continued Disparities in Adults: United States, 2005-2006. NCHS Data Brief No 3. Hyattsville, MD: National Center for Health Statistics; 2008. Available at http://www.cdc.gov/nchs/data/databriefs/db03.pdf. Accessed June 2009.
17. M.A. van der Sande R. Bailey H. Faal, et al. 1997 Nationwide prevalence study of hypertension and related non-communicable diseases in The Gambia Trop Med Int Health 2 1039 1048 10.1046/j.1365-3156.1997.d01-184.x 9391506
18. R.S. Vasan A. Beiser Seshadri, et al. 2002 Residual lifetime risk for developing hypertension in middle-aged men women and men: The Framingham Heart Study JAMA 287 1003 1010 10.1001/jama.287.8.1003 11866648
19. V.L. Burt P. Whelton E.J. Roccella, et al. 1995 Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991 Hypertension 25 305 313 1:STN:280:DyaK2M7otV2gsA%3D%3D 7875754
20. T.A. Hodgson L. Cai 2001 Medical care expenditures for hypertension, its complications, and its comorbidities Med Care 39 599 615 10.1097/00005650- 200106000-00008 1:STN:280:DC%2BD3MzjsVykuw%3D%3D 11404643 (Pubitemid 33603645)
21. Cherry DK, Woodwell DA: National Ambulatory Medical Care Survey: 2000 Summary. Advance Data From Vital and Health Statistics; No. 328. Hyattsville, MD: National Center for Health Statistics; 2002. Available at http://www.cdc.gov/nchs/data/ad/ad328.pdf. Accessed June 2009.
22. D.K. Cherry D.A. Woodwell 2002 National Ambulatory Medical Care Survey: 2000 Summary. Advance Data From Vital and Health Statistics; No. 328 National Center for Health Statistics Hyattsville, MD Cherry DK, Woodwell DA: National Ambulatory Medical Care Survey: 2000 Summary. Advance Data From Vital and Health Statistics; No. 328. Hyattsville, MD: National Center for Health Statistics; 2002. Available at http://www.cdc.gov/nchs/data/ad/ad328.pdf. Accessed June 2009.
23. American Heart Association: 2002 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association; 2001. Available at http://www. americanheart.org/downloadable/heart/HS-State-02.pdf. Accessed June 2009.
24. American Heart Association 2001 2002 Heart and Stroke Statistical Update American Heart Association Dallas, TX American Heart Association: 2002 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association; 2001. Available at http://www.americanheart.org/downloadable/heart/HS-State-02.pdf. Accessed June 2009.
25. Cherry DK, Hing E, Woodwell DA, Rechtsteiner EA: National Ambulatory Medical Care Survey: 2006 Summary. National Health Statistics Reports; No. 3. Hyattsville, MD: National Center for Health Statistics; 2008. Available at http://www.cdc.gov/nchs/data/nhsr/nhsr003.pdf. Accessed June 2009.
26. D.K. Cherry E. Hing D.A. Woodwell E.A. Rechtsteiner 2008 National Ambulatory Medical Care Survey: 2006 Summary. National Health Statistics Reports; No. 3 National Center for Health Statistics Hyattsville, MD Cherry DK, Hing E, Woodwell DA, Rechtsteiner EA: National Ambulatory Medical Care Survey: 2006 Summary. National Health Statistics Reports; No. 3. Hyattsville, MD: National Center for Health Statistics; 2008. Available at http://www.cdc.gov/ nchs/data/nhsr/nhsr003.pdf. Accessed June 2009.
27. D. Lloyd-Jones R. Adams M. Carnethon, et al. 2009 Heart disease and stroke statistics 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 119 e21 e181 10.1161/CIRCULATIONAHA.108.191261 19075105
28. J.A. Cutler P.D. Sorlie M. Wolz, et al. 2008 Trends in hypertension prevalence, awareness, treatment and control rates in United States adults between 1988-1994 and 1999-2004 Hypertension 52 818 827 10.1161/HYPERTENSIONAHA. 108.113357 1:CAS:528:DC%2BD1cXht1GgtbjJ 18852389
29. ALLHAT OfficersCoordinators for the ALLHAT Collaborative Research Group 2004 Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2981 2997 10.1001/jama.288.23.2981
30. The Trials of Hypertension Prevention Collaborative Research Group 1997 Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II Arch Intern Med 157 657 667 10.1001/archinte.157.6.657
31. J. He P.K. Whelton L.J. Appel, et al. 2000 Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension Hypertension 35 544 549 1:STN:280:DC%2BD3c7ksFynug%3D%3D 10679495
32. X. Xin J. He M.G. Frontini, et al. 2001 Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials Hypertension 38 1112 1117 10.1161/hy1101.093424 1:CAS:528:DC%2BD3MXovVOrsbY%3D 11711507
33. F.M. Sacks L.P. Svetkey W.M. Vollmer, et al. 2001 Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group N Engl J Med 344 3 10 10.1056/NEJM200101043440101 1:STN:280:DC%2BD3M7ksVSqsQ%3D%3D 11136953 (Pubitemid 32064838)
34. National High Blood Pressure Education Program 1997 The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Arch Intern Med 157 2413 2446 10.1001/archinte.157.21. 2413
35. L.J. Appel T.J. Moore E. Obarzanek, et al. 1997 A clinical trial of the effects of dietary patterns on blood pressure N Engl J Med 336 1117 1124 10.1056/NEJM199704173361601 1:STN:280:DyaK2s3jvVOmsA%3D%3D 9099655 (Pubitemid 27374693)
36. R.D. Mattes D. Donnely 1991 Relative contributions of dietary sodium sources J Am Coll Nutr 10 383 393 1:STN:280:DyaK3MzntlOrug%3D%3D 1910064
37. G.A. Kelley K.S. Kelley 2000 Progressive resistance exercise and resting blood pressure: a meta-analysis of randomized controlled trials Hypertension 35 838 843 1:STN:280:DC%2BD3c7oslCgsQ%3D%3D 10720604
38. S.P. Whelton A. Chin X. Xin J. He 2002 Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials Ann Intern Med 136 493 503 11926784
39. T. Forrester R.S. Cooper D. Weatherall 1998 Emergence of Western diseases in the tropical world: the experience with chronic cardiovascular diseases Br Med Bull 54 463 473 1:STN:280:DyaK1M%2Fksl2jsA%3D%3D 9830210
40. N.R. Cook J. Cohen P.R. Hebert, et al. 1995 Implications of small reductions in diastolic blood pressure for primary prevention Arch Intern Med 155 701 709 10.1001/archinte.155.7.701 1:STN:280:DyaK2M3gvFGjtA%3D%3D 7695458
41. R. Collins R. Peto S. MacMahon, et al. 1990 Blood pressure, stroke, and coronary heart disease. Part 2: short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context Lancet 335 827 838 10.1016/0140-6736(90)90944-Z 1:STN:280:DyaK3c3gsFeruw%3D%3D 1969567 (Pubitemid 20113741)
42. J. He P.K. Whelton 1999 Elevated systolic blood pressure as a risk for cardiovascular and renal disease J Hypertens 335Suppl17 S7 S13
43. R. Cooper C. Rotini 1997 Hypertension in blacks Am J Hypertens 7 804 812 10.1016/S0895-7061(97)00211-2 (Pubitemid 27313828)
44. J.T. Wright Jr J.K. Dunn J.A. Cutler, et al. 2005 Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril JAMA 293 1595 1607 10.1001/jama.293.13.1595 1:CAS:528:DC%2BD2MXjtV2rur8%3D 15811979 (Pubitemid 40471790)
45. M.T. Kim K.B. Kim H.S. Juon M.N. Hill 2000 Prevalence and factors associated with high blood pressure in Korean Americans Ethn Dis 10 364 374 1:STN:280:DC%2BD3Mvps1Cltw%3D%3D 11110353
46. National Heart, Lung, and Blood Institute: Strategy for addressing health disparities: FY 2002-2006. Available at http://www.nhlbi.nih.gov/resources/ docs/plandisp.htm. Accessed June 2009.
47. M.A. Krousel-Wood P. Muntner J. He, et al. 2004 Primary prevention of essential hypertension Med Clin N Am 88 223 238 10.1016/S0025-7125(03)00126-3 14871061 (Pubitemid 38160947)
48. G.A. Mensah 2002 The global burden of hypertension: good news and bad news Cardiol Clin 20 181 185 10.1016/S0733-8651(02)00002-4 12119794 (Pubitemid 34803322)
49. P.K. Whelton J. He P. Muntner 2004 Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia J Hum Hypertens 18 545 551 10.1038/sj.jhh.1001701 1:STN:280:DC%2BD2czms1ajug%3D%3D 15269704 (Pubitemid 39173530)
50. R.S. Cooper B. Osotimehin J.S. Kaufman, et al. 1998 Disease burden in sub-Saharan Africa: what should we conclude in the absence of data? Lancet 351 208 210 10.1016/S0140-6736(97)06512-4 1:STN:280:DyaK1c7htFGgtQ%3D%3D 9449884 (Pubitemid 28037018)
51. N.D. Markandu F. Whitcher A. Arnold, et al. 2000 The mercury sphygmomanometer should be abandoned before it is proscribed J Hum Hypertens 14 31 36 10.1038/sj.jhh.1000932 1:STN:280:DC%2BD3c7jvFGgsA%3D%3D 10673728 (Pubitemid 30113628)
52. D.J. Hyman V.N. Pavlik 2000 Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine Arch Intern Med 160 2281 2286 10.1001/archinte.160.15.2281 1:STN:280:DC%2BD3cvhs12isA%3D%3D 10927724
53. S.L. Ataman R. Cooper C. Rotimi, et al. 1996 Standardization of blood pressure measurement in an international comparative study J Clin Epidemiol 49 869 877 10.1016/0895-4356(96)00111-4 1:STN:280:DyaK28zis1eltQ%3D%3D 8699206 (Pubitemid 26283398)
54. World Health Organization: Integrated Management of Cardiovascular Risk: Report of a WHO Meeting, Geneva, 9-12 July 2002. Geneva, Switzerland: World Health Organization; 2002. Available at http://whqlibdoc.who. int/publications/9241562242.pdf. Accessed June 2009.
55. E. O'Brien J. Petrie W.A. Littler, et al. 1993 The British Hypertension Society protocol for the evaluation of blood pressure measuring devices J Hypertens 11 Suppl2 S43 S63
56. Association for the Advancement of Medical Instrumentation: American National Standard for Electronic or Automated Sphygmomanometers. ANSI/AAMI SP 10-1992. Arlington, VA: AAMI, 1993:40.
57. G. Parati S. Mendis D. Abegunde, et al. 2005 Recommendations for blood pressure measuring devices for office/clinic use in low resource settings Blood Press Monit 10 3 10 10.1097/00126097-200502000-00002 15687867 (Pubitemid 40316145)
58. World Health Organization: WHO CVD-Risk Management Package for Low- and Medium-Resource Settings. Geneva, Switzerland: World Health Organization; 2002. Available at http://whqlibdoc.who.int/publications/2002/9241545852.pdf. Accessed June 2009.
59. World Health Organization 2002 WHO CVD-Risk Management Package for Low- and Medium-Resource Settings World Health Organization Geneva, Switzerland World Health Organization: WHO CVD-Risk Management Package for Low- and Medium-Resource Settings. Geneva, Switzerland: World Health Organization; 2002. Available at http://whqlibdoc.who.int/publications/2002/9241545852.pdf. Accessed June 2009.